Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder CancerHomayoun Zargar, Peter C. Black, Nikhil Vasdev et al.|European Urology|2014Cited by 297
The prognostic value of the neutrophil-to-lymphocyte ratio in patients with muscle-invasive bladder cancer treated with neoadjuvant chemotherapy and radical cystectomyAnna J. Black, Peter C. Black, Homayoun Zargar et al.|Urologic Oncology Seminars and Original Investigations|2019Cited by 44
Salvage Robot-assisted Renal Surgery for Local Recurrence After Surgical Resection or Renal Mass Ablation: Classification, Techniques, and Clinical OutcomesAlberto Martini, Juan Gómez Rivas, Filippo Turri et al.|European Urology|2021Cited by 25
Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancerDavid D‘Andrea, Shahrokh F. Shariat, Peter C. Black et al.|Urologic Oncology Seminars and Original Investigations|2020Cited by 23
Concomitant CIS on TURBT does not impact oncological outcomes in patients treated with neoadjuvant or induction chemotherapy followed by radical cystectomyNikhil Vasdev, Peter C. Black, Homayoun Zargar et al.|World Journal of Urology|2018Cited by 9